ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ASP African Pioneer Plc

3.75
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
African Pioneer Plc LSE:ASP London Ordinary Share IM00B8C0HK22 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.75 3.50 4.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

African Pioneer Share Discussion Threads

Showing 3301 to 3324 of 3450 messages
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
19/1/2007
09:04
yup. Breakout time.
wjccghcc
19/1/2007
08:26
Strong institutional demand will see the share price well through 50p over the next few months.
ltinvestor
19/1/2007
08:12
... and again today

getting very close to that 50p now

currypasty
18/1/2007
07:48
Opening up this morning
currypasty
13/1/2007
09:33
The institutions are climbing on board, attracted by the earnings visibility and future growth.Around 3m shares were booked on Thursday at 45p.
ltinvestor
12/1/2007
15:49
730k trade at 45p... I wonder if that is half of the sahres from the 2 directors... house broker is cnks, and they have been on the ask.. bound to be them that took the directors shares... perhaps they even requested them to improve liquidity..
currypasty
11/1/2007
15:07
must be due another tick up, look at all the buys going through
currypasty
11/1/2007
10:22
new all time high, looking very bullish
currypasty
11/1/2007
10:11
With £4m pre tax to year end June 07 forecast the present p/e ratio is ,imho, far too low for a company growing at this rate.
ltinvestor
11/1/2007
08:44
Agreed. Been following them for a while and finally bought yesterday. It looks like the NHS-wide contract turbulence is helping them as hospitals move to procurement on a localised basis. Nice to have cashflow conversion >100% op profits as well :-)
wjccghcc
11/1/2007
08:24
GOOD START THIS MORNING
currypasty
10/1/2007
09:19
Is this stock the next Isoft without the downside?
manchesterbill
10/1/2007
09:12
82,000 buy at open helped the price this morning!
currypasty
10/1/2007
07:57
In December alone, we took orders for over #3.3 million
currypasty
10/1/2007
07:46
50p sooner than we thought !
currypasty
10/1/2007
07:45
Ascribe Trading Statement


RNS Number:2549P Ascribe plc 10 January 2007 Press Release 10 January 2007 Ascribe plc ("Ascribe" or "the Group") Trading Update Ascribe plc (AIM:ASP), the health IT Group, is pleased to announce that the trading performance for the six months ended 31 December 2006 was in line with market expectations and that the directors are confident about the prospects for the full year. The Group is continuing to demonstrate robust growth and successful integration of new acquisitions. All areas of the business are performing well and trading in every division is ahead of last year. The Directors expect to maintain significant sales growth for the remainder of the year as the Group continues to win market share. Ascribe's Pharmacy Division has won several new health IT contracts in the first half-year. These include the sale of Ascribe's Pharmacy Department and Electronic Prescribing solutions to: Addenbrookes Hospital; Mid-Cheshire Hospitals NHS Trust; Hereford Hospital NHS Trust; Tees, Esk & Wear Valleys NHS Trust; and Airedale Hospital. The division has also started to transfer customers to its new web-based pharmacy solution and has made sales to: Derbyshire Mental Health Services in the UK; Tauranga & Whakatane Hospitals in New Zealand's Bay of Plenty District Health Board; and the Northern Territories' Department of Health & Community Services in Australia. These contracts yield recurring maintenance income for a minimum period of between three and five years, being the length of the initial contract, and enhance further the visibility of the Group's earnings. Our Primary and Unscheduled Care Division has also won several new contracts including the sale of Accident & Emergency systems to Guy's & St Thomas' Hospital Trust, Hammersmith Hospitals NHS Trust and Antrim Hospital. We have also secured an order from West Kent Primary Care Trust (PCT) for the provision of a software system for the Urgent Care Centre operated by the PCT at the Darent Valley Hospital, part of the Dartford and Gravesham NHS Trust. As with our Pharmacy Division, some of these contracts include maintenance income for five-year periods. Ascribe's Mental Health and Community Care division has continued to build upon the new business opportunities secured when its 'messaging engine' was approved by Connecting for Health. In addition to this, we have received significant new business through recent acquisitions; sales of our mental health & community care solutions are performing well with orders placed by Central & North West London and Vision Australia in December. Our Electronic Patient Record division, formed from the newly acquired HE Information Systems and Barwick Systems, has similarly performed well and added value to our order book and new sales. In this half year, orders have been placed by the Hospital NHS Trusts for Royal Bournemouth & Christchurch, County Durham & Darlington, Bradford, Poole, Papworth and South Tees. With recurring maintenance contract revenues in excess of 60 per cent of sales, a healthy order book and a continuing high level of tendering activity - both in the UK and overseas - the Board expects that Ascribe will continue to perform in line with expectations in the second half of the financial year, ending 30 June 2007. Stephen Critchlow, Executive Chairman of Ascribe, said: "Having broadened the solutions that we offer using our integrated platform, I am pleased to report that this has been our best half-year so far for new orders. In December alone, we took orders for over #3.3 million. "We are now benefiting from three key influences: firstly, the consolidated and expanded management of the Group; secondly, we have seen a shift in the last six months towards local purchasing of healthcare IT solutions in the UK, further broadening our opportunities; and thirdly, we have seen significant growth in orders from our overseas customers." "We are now able to demonstrate our ability to be a dominant player in Health IT; this stems directly from our reputation for delivering robust products and focusing upon the needs of the clinician at the point of care. I am pleased to report that our order book is strong and the Board expects to deliver another good result for the full year." The interim results for the period to 31 December 2006 are expected to be announced on 21 March 2007. - Ends - For further information, please contact: Ascribe plc Stephen Critchlow, Executive Chairman Tel: +44 (0) 8700 53 45 45 stephen.critchlow@ascribe.com www.ascribe.com Media enquiries: Abchurch Justin Heath / Stephanie Cuthbert Tel: +44 (0) 20 7398 7700 stephanie.cuthbert@abchurch-group.com www.abchurch-group.com Notes to editors Ascribe plc is a leading healthcare company that develops and markets software solutions supporting patient, clinical and business processes to Primary & Secondary healthcare providers in the UK and overseas. Ascribe is committed to providing technologies that improve patient safety standards and the company's solutions directly improve patient care and deliver financial savings to customers. The group sells directly to hospitals and Primary Care Trusts rather than through centrally driven political initiatives. The Group provides solutions to clinical professionals in all healthcare sectors; customers include Emergency and Minor Injuries Units, Mental Health and Social Care Units, Hospitals requiring patient administration systems (PAS) and medical equipment management, Hospital and Retail Pharmacies, and General Practice surgeries. Offering patient and decision support information to these clinicians in context with their activity is the key to the company's ongoing success. Ascribe plc was floated on AIM in 2004, and currently employs over 200 personnel through its seven operating companies in the UK, Hong Kong, Kenya, Australia and New Zealand. For more information, please visit www.ascribe.com. (c) Ascribe 2007. Ascribe is a registered trademark of Ascribe plc. All other brands and product names and trademarks are the registered property of their respective companies. This information is provided by RNS The company news service from the London Stock Exchange END TSTUUUGPGUPMGMB

currypasty
09/1/2007
16:15
I think that we have a fair chance of 50p over the next few months.
ltinvestor
09/1/2007
14:20
It looks to me like punters took the lead from the recent directors selling, and offloaded a few at 40p ish. Perhaps now they are gone, the price can start off again ?

although directors did sell a few, they still have 15.8 mil, and 11.3 mil left, which is one heck of an incentive to keep the ball rolling

currypasty
22/12/2006
12:48
RNS Number:6135O
Ascribe plc
22 December 2006


Ascribe plc (the "Company")

Holding in Company

22 December 2006




The Company was informed on 21 December 2006 that Christopher Jones, on 21
December 2006 sold 750,000 ordinary shares of 1p each in the Company ("Ordinary
Shares") at a price of 40p per share. Mr Jones' interest following this
transfer stands at 15,803,747 Ordinary Shares, which represents 13.84 per cent.
of the Company's current issued share capital.


The Company was also informed on 21 December 2006 that Richard Bradshaw, on 21
December 2006 sold 750,000 Ordinary Shares at a price of 40p per share. Mr
Bradshaw's interest following this transfer stands at 11,385,244 Ordinary
Shares, which represents 9.97 per cent. of the Company's current issued share
capital.

currypasty
11/12/2006
09:53
profit takers moved on, buyers returning

40.0 - 43.0

currypasty
06/12/2006
16:22
A bit of profit taking today, could also be market makers trying to force some shares... 100k T could be a buy
currypasty
05/12/2006
15:51
CURRY,

Cenkos have been on the offer for ages, and almost certainly had the seller, which has been holding the price back.

I was tempted to buy some more yesterday when the price nudged better on little volume.

When a share price breaks into new high ground, it is difficult to know when to get off, especially as the historic rating looks full. But what is the prospective rating?

There is obviously a story going round, unless a few momentum traders/chartists have picked up on it.

I've got a nice profit, but want to maximise it, so I think I will hold for the time being.

tiltonboy

tiltonboy
05/12/2006
15:33
tilton... just as you mention 'profit taking' its up more !
currypasty
05/12/2006
14:57
its been mentioned on
yesterday

dbj the first
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older

Your Recent History

Delayed Upgrade Clock